Ocular allergy von Friedlaender, Mitchell H

Volltext

Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy von Friedlaender, Mitchell H, Protzko, Eugene

Volltext

The dilution of benzalkonium chloride (BAK) in the tear film von Friedlaender, Mitchell H, Breshears, Daphne, Amoozgar, Bahram, Sheardown, Heather, Senchyna, Michelle

Volltext

Development of a Topical Polymeric Mucoadhesive Ocular Delivery System for Azithromycin von BOWMAN, Lyle M, SI, Erwin, PANG, Joseph, ARCHIBALD, Roy, FRIEDLAENDER, Mitchell

Volltext

Objective measurement of allergic reactions in the eye von Friedlaender, Mitchell H

Volltext

Conjunctival provocation testing: overview of recent clinical trials in ocular allergy von Friedlaender, Mitchell H

Volltext

A Double-masked, Placebo-controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Treatment of Giant Papillary Conjunctivitis von FRIEDLAENDER, MITCHELL H., HOWES, JOHN, THE LOTEPREDNOL ETABONATE GIANT PAPILLARY CONJUNCTIVITIS STUDY GROUP I

Volltext

Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis von Friedlaender, Mitchell H, Protzko, Eugene

Volltext

Evaluation of the onset and duration of effect of Azelastine Eye Drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model von Friedlaender, Mitchell H, Harris, Judith, LaVallee, Nicole, Russell, Heidy, Shilstone, Jonathan

Volltext

Conjunctival provocation testing: overview of recent clinical trials in ocular allergy von Friedlaender, Mitchell H

Volltext

Blepharitis, allergy, and dry eye: lumpers and splitters von Friedlaender, Mitchell H

Volltext

Phakic intraocular lens for myopia von Friedlaender, Mitchell H

Volltext

The current and future therapy of allergic conjunctivitis von Friedlaender, Mitchell H

Volltext

Conjunctivitis of allergic origin: Clinical presentation and differential diagnosis von Friedlaender, Mitchell H.

Volltext

Clinical development of 1% azithromycin in DuraSite super(ARG), a topical azalide anti-infective for ocular surface therapy von Friedlaender, Mitchell H, Protzko, Eugene

Volltext

Overview of ocular allergy treatment von Friedlaender, M

Volltext

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis von Schwab, Ivan R, Friedlaender, Mitchell, McCulley, James, Lichtenstein, Steven J, Moran, C.Thomas

Volltext

Conjunctival provocation testing: Overview of recent clinical trials in ocular allergy: Recent trends in ocular allergy von FRIEDLAENDER, Mitchell H

Volltext

Presbyopia von FRIEDLAENDER, Mitchell H

Volltext

Preface von Friedlaender, Mitchell H.

Volltext